Nalbuphine Hydrochloride 70069-0662
Product NDC
70069-0662- Manufacturer
- Somerset Therapeutics, Llc
- Dosage Form
- Injection
- Route
- Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 26, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA216049
Need to source Nalbuphine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nalbuphine Hydrochloride | 20 mg/mL |
Drug Class
Competitive Opioid Antagonists [MoA]Opioid Agonist/Antagonist [EPC]Partial Opioid Agonists [MoA]
Packaging Options(1)
1 VIAL, MULTI-DOSE in 1 CARTON (70069-662-10) / 10 mL in 1 VIAL, MULTI-DOSE